TABLE OF CONTENTS
Volume 43, Issue 2 (January (2) 2009)
Obituary
In memory of Reginald Clift, 1929–2008
Rainer Storb
Bone Marrow Transplant 43: 89-90; doi:10.1038/bmt.2008.418
Review
In pursuit of the allo-immune response in multiple myeloma: where do we go from here?
G Cook, J M Bird and D I Marks
Bone Marrow Transplant 43: 91-99; advance online publication, December 15, 2008; doi:10.1038/bmt.2008.397
Original Articles
Cell Procurement
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma
E Copelan, B Pohlman, L Rybicki, M Kalaycio, R Sobecks, S Andresen, R Dean, A Koo, J Chan, J Sweetenham and B Bolwell
Bone Marrow Transplant 43: 101-105; advance online publication, September 15, 2008; doi:10.1038/bmt.2008.306
Allografting
Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival
M J Burke, B Trotz, X Luo, K S Baker, D J Weisdorf, J E Wagner and M R Verneris
Bone Marrow Transplant 43: 107-113; advance online publication, September 8, 2008; doi:10.1038/bmt.2008.296
Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India
R Kumar, R Naithani, P Mishra, M Mahapatra, T Seth, T K Dolai, R Bhargava and R Saxena
Bone Marrow Transplant 43: 115-119; advance online publication, September 15, 2008; doi:10.1038/bmt.2008.307
Post-Transplant Events
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT
L Gil, M Kozlowska-Skrzypczak, A Mol, D Poplawski, J Styczynski and M Komarnicki
Bone Marrow Transplant 43: 121-126; advance online publication, September 15, 2008; doi:10.1038/bmt.2008.303
Focal nodular hyperplasia of the liver following hematopoietic SCT
H Sudour, L Mainard, C Baumann, L Clement, A Salmon and P Bordigoni
Bone Marrow Transplant 43: 127-132; advance online publication, September 22, 2008; doi:10.1038/bmt.2008.304
Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center
R Guilfoyle, A Demers, C Bredeson, E Richardson, M Rubinger, D Szwajcer and M D Seftel
Bone Marrow Transplant 43: 133-139; advance online publication, September 1, 2008; doi:10.1038/bmt.2008.300
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT
S McCann, M Schwenkglenks, P Bacon, H Einsele, A D'Addio, J Maertens, D Niederwieser, W Rabitsch, A Roosaar, T Ruutu, H Schouten, R Stone, S Vorkurka, B Quinn and N Blijlevens on behalf of the EBMT Mucositis Advisory Group
Bone Marrow Transplant 43: 141-147; advance online publication, September 8, 2008; doi:10.1038/bmt.2008.299
Graft-Versus-Host Disease
New classification of chronic GVHD: added clarity from the consensus diagnoses
M Arora, S Nagaraj, J Witte, T E DeFor, M MacMillan, L J Burns and D J Weisdorf
Bone Marrow Transplant 43: 149-153; advance online publication, September 15, 2008; doi:10.1038/bmt.2008.305
Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients
M Akhtari, A A Langston, E K Waller and A A Gal
Bone Marrow Transplant 43: 155-158; advance online publication, September 15, 2008; doi:10.1038/bmt.2008.302
Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT
K Oda, C Nakaseko, S Ozawa, M Nishimura, Y Saito, F Yoshiba, T Yamashita, H Fujita, H Takasaki, H Kanamori, A Maruta, H Sakamaki and S Okamoto for the Kanto Study Group for Cell Therapy (KSGCT)
Bone Marrow Transplant 43: 159-167; advance online publication, September 1, 2008; doi:10.1038/bmt.2008.297
Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma
W R Drobyski, P Hari, C Keever-Taylor, R Komorowski and W Grossman
Bone Marrow Transplant 43: 169-177; advance online publication, September 1, 2008; doi:10.1038/bmt.2008.295
Letter to the Editor
Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT
A E Donker, P M Hoogerbrugge, A M C Mavinkurve-Groothuis, N C A J van de Kar, C Boetes, C A Hulsbergen-van de Kaa and J J Groot-Loonen
Bone Marrow Transplant 43: 179-180; advance online publication, September 1, 2008; doi:10.1038/bmt.2008.301
